Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Mary E. Klotman"'
Autor:
Alessandra Gallinaro, Maria Franca Pirillo, Yoann Aldon, Serena Cecchetti, Zuleika Michelini, Antonella Tinari, Martina Borghi, Andrea Canitano, Paul F. McKay, Roberta Bona, Maria Fenicia Vescio, Felicia Grasso, Maria Blasi, Silvia Baroncelli, Gabriella Scarlatti, Celia LaBranche, David Montefiori, Mary E. Klotman, Rogier W. Sanders, Robin J. Shattock, Donatella Negri, Andrea Cara
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-13 (2022)
Abstract Integrase Defective Lentiviral Vectors (IDLVs) represent an attractive vaccine platform for delivering HIV-1 antigens, given their ability to induce specific and persistent immune responses in both mice and non-human primates (NHPs). Recent
Externí odkaz:
https://doaj.org/article/94f8ebf4de2b4e68add95d41c53acdd3
Autor:
Roberta Bona, Zuleika Michelini, Chiara Mazzei, Alessandra Gallinaro, Andrea Canitano, Martina Borghi, Maria Fenicia Vescio, Antonio Di Virgilio, Maria Franca Pirillo, Mary E. Klotman, Donatella Negri, Andrea Cara
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 263-275 (2021)
Integrase-defective lentiviral vectors (IDLVs) represent an attractive platform for vaccine development as a result of the ability to induce persistent humoral- and cellular-mediated immune responses against the encoded transgene. Compared with the p
Externí odkaz:
https://doaj.org/article/fb5aec3a55ec447ebb7f66eedf533028
Autor:
Yi-Yu Lin, Ian Belle, Maria Blasi, Min-Nung Huang, Anne F. Buckley, Wes Rountree, Mary E. Klotman, Andrea Cara, Donatella Negri
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 532-544 (2020)
We previously developed integrase-defective lentiviral vectors (IDLVs) as an antigen delivery system for inducing strong and prolonged immunity in animal models. Here, we examined the association between persistence of antigen expression and durabili
Externí odkaz:
https://doaj.org/article/103e5f7dba2742d492fc44ae81fb0b05
Autor:
Chiara Mazzei, Andrea Cara, Andrea Canitano, Donatella R.M. Negri, Martina Borghi, Roberta Bona, Maria Fenicia Vescio, Mary E. Klotman, Zuleika Michelini, Maria Franca Pirillo, Alessandra Gallinaro, Antonio Di Virgilio
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss, Pp 263-275 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development
Integrase-defective lentiviral vectors (IDLVs) represent an attractive platform for vaccine development as a result of the ability to induce persistent humoral- and cellular-mediated immune responses against the encoded transgene. Compared with the p
Publikováno v:
J Virol
HIV-1 persistence in different cell types presents the main obstacle to an HIV-1 cure. We have previously shown that the renal epithelium is a site of HIV-1 infection and that the kidney represents a separate viral compartment from blood. Whether ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973d2530ad7f163a23f336830d382166
https://europepmc.org/articles/PMC9327708/
https://europepmc.org/articles/PMC9327708/
Publikováno v:
AIDS
People living with HIV are at higher risk for acute and chronic kidney disease compared with uninfected individuals. Kidney disease in this population is multifactorial, with several contributors including HIV infection of kidney cells, chronic infla
Publikováno v:
AIDS
ObjectivesHIV-1 can infect and persist in different organs and tissues, resulting in the generation of multiple viral compartments and reservoirs. Increasing evidence supports the kidney as such a reservoir. Previous work demonstrated that HIV-1 infe
Autor:
Celia C. LaBranche, Benjamin Mildenberg, Sampa Santra, Andrea Cara, Barton F. Haynes, Erich J Baker, Donatella R.M. Negri, Maria Blasi, Mary E. Klotman, M. Anthony Moody, Wes Rountree, Kevin O. Saunders, Elizabeth C Wescott
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-9 (2020)
npj Vaccines
NPJ Vaccines
npj Vaccines
NPJ Vaccines
Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of th
Autor:
Silvia Baroncelli, Celia C. LaBranche, Robin J. Shattock, Andrea Canitano, Antonella Tinari, Martina Borghi, Rogier W. Sanders, Serena Cecchetti, Maria Blasi, Roberta Bona, Felicia Grasso, Paul F. McKay, Maria Fenicia Vescio, David C. Montefiori, Donatella R.M. Negri, Yoann Aldon, Maria Franca Pirillo, Andrea Cara, Alessandra Gallinaro, Mary E. Klotman, Zuleika Michelini, Gabriella Scarlatti
Integrase Defective Lentiviral Vectors (IDLVs) represent an attractive vaccine platform for delivering HIV-1 antigens, given their ability to induce specific and persistent immune responses in both mice and non-human primates (NHPs). Recent advances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f798569720a2393992c4de668d0566d3
https://doi.org/10.1101/2021.10.08.462761
https://doi.org/10.1101/2021.10.08.462761
Autor:
Alessandra Gallinaro, Maria Franca Pirillo, Yoann Aldon, Serena Cecchetti, Zuleika Michelini, Antonella Tinari, Martina Borghi, Andrea Canitano, Paul F. McKay, Roberta Bona, Maria Fenicia Vescio, Felicia Grasso, Maria Blasi, Silvia Baroncelli, Gabriella Scarlatti, Celia LaBranche, David Montefiori, Mary E. Klotman, Rogier W. Sanders, Robin J. Shattock, Donatella Negri, Andrea Cara
Publikováno v:
npj Vaccines, 7(1):44. Nature Publishing Group
npj Vaccines
npj Vaccines
Integrase Defective Lentiviral Vectors (IDLVs) represent an attractive vaccine platform for delivering HIV-1 antigens, given their ability to induce specific and persistent immune responses in both mice and non-human primates (NHPs). Recent advances